Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies

Por Langabeer, Stephen E., Haslam, Karl, Conneally, Eibhlin
Publicado em 2014

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation

Por Langabeer, Stephen E., Nolan, James, Haslam, Karl, Clarke, Lindsey, Flavin, Richard, Conneally, Eibhlin
Publicado no Case Rep Hematol (2015)

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia

Por Haslam, Karl, Langabeer, Stephen E., Kelly, Johanna, Coen, Natasha, O'Connell, Niamh M., Conneally, Eibhlin
Publicado em 2012

Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation

Por Hayat, Amjad, McCann, Shaun R., Langabeer, Stephen, Irvine, Sandra, McMullin, Mary Frances, Conneally, Eibhlin
Publicado em 2009

Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring

Por Crampe, Mireille, Haslam, Karl, Groarke, Emma, Kelleher, Eileen, O'Shea, Derville, Conneally, Eibhlin, Langabeer, Stephen E.
Publicado no Case Rep Hematol (2017)

Ex-vivo Sensitivity Profiling to Guide Clinical Decision Making in Acute Myeloid Leukemia: A Pilot Study

Por Swords, Ronan T, Azzam, Diana, Al-Ali, Hassan, Lohse, Ines, Volmar, Claude-Henry, Watts, Justin M., Perez, Aymee, Rodriguez, Ana, Vargas, Fernando, Elias, Roy, Vega, Francisco, Zelent, Arthur, Brothers, Shaun P., Abbasi, Taher, Trent, Jonathan, Rangwala, Shaukat, Deutsch, Yehuda, Conneally, Eibhlin, Drusbosky, Leylah, Cogle, Christopher R., Wahlestedt, Claes
Publicado no Leuk Res (2017)